Results 91 to 100 of about 19,421 (203)

Perbandingan Efektifitas dan Keamanan Pemberian Nevirapine Dosis Tunggal dan Dosis terbagi Sebagai Kombinasi Terapi Antiretroviral pada Pasien Hiv/Aids

, 2013
Introduction: Antiretroviral treatment administration once a day has a few influence toward the life style, and easy to remember so it will improve treatment compliance.
Peranginangin, Senior Tawarta
core  

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

, 2009
Contains fulltext : 81637.pdf (Publisher’s version ) (Open Access)BACKGROUND: This collaboration of seven observational clinical cohorts investigated risk factors for treatment-limiting toxicities in both antiretroviral-naive and ...
Julio S. Montaner, Amanda Mocroft, Jose M Gatell, Reiss, Peter, Wit, Ferdinand W, Gill, M. John, NN, NN, Lundgren, Jens D., Wolf, F. de, Frank de Wolf, Mocroft, A., Lundgren, J.D., Sabin, Caroline A, VULLO, Vincenzo, Montaner, Julio S, Mocroft, Amanda, Andri Rauch, Gill, M John, Phillips, E., Jens D Lundgren, Sabin, Caroline A., Lundgren, Jens D, ?, ?, Schölvinck, Elisabeth H., Caroline A. Sabin, Jens D. Lundgren, M. John Gill, Gatell, Jose M., Ven, A.J.A.M. van der, Peter Reiss, Vandekerckhove, Linos, et al., de Wolf, Frank, M John Gill, Julio S Montaner, Kesselring, A.M., Sabin, C.A., Gatell, J.M., Nevirapine Toxicity Multicohort, the, Wit, Ferdinand W., Gill, M.J., Gatell, Jose M, Ferdinand W Wit, Rauch, A., Kesselring, Anouk M, Anouk M. Kesselring, Montaner, Julio S., Nevirapine Toxicity Multicohort Collaboration, Rauch, Andri, F. De Wolf, Kesselring, Anouk M., Jose M. Gatell, Anouk M Kesselring, Post, Frank, Caroline A Sabin, Wit, Ferndinand W, Gyssens, I.C.J., Ferdinand W. Wit, de Wolf, F., Montaner, J.S., Wit, F.W., Reiss, P.   +61 more
core   +1 more source

Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies.

, 2005
Contains fulltext : 48952.pdf (Publisher’s version ) (Open Access)BACKGROUND: Single-dose nevirapine is a highly cost-effective strategy to reduce perinatal HIV-1 transmission.
Burger, D.M., Hofstede, H.J.M. ter, Bosch, M., Dolmans, W.M.V., Droste, J.A.H., Muro, E.P.   +5 more
core   +1 more source

Nelfinavir and nevirapine side effects during pregnancy

, 2005
Background: The risk of vertical transmission of HIV has been substantially reduced since the introduction of highly active antiretroviral therapy (HAART); however, the impact of taking HAART during pregnancy on the woman, the fetus and the infant is not
Timmermans, S, Sprenger, H, Boer, K, Nellen, J, Godfried, MH, Tempelman, C, Schneider, MEE, van der Ende, Marchina E., de Wolf, F   +8 more
core   +3 more sources

SPECTROPHOTOMETRIC DETERMINATION OF NEVIRAPINE USING TETRATHIOCYANATOCOBALT(II) ION AS A REAGENT

Eclética Química, 2018
A simple and rapid spectrophotometric method for the determination of nevirapine is described. The method is based on the reaction of nevirapine with tetrathiocyanatocobalt(II) ion in buffer of pH 4 to form the corresponding complex. Beer’s law is obeyed
T. V. Badiadka, Badiadka Narayana
doaj   +1 more source

The impact of a Wastewater Treatment Works in Southern Gauteng, South Africa on efavirenz and nevirapine discharges into the aquatic environment

Emerging Contaminants, 2017
There has been growing concern regarding the pollution of the aquatic environment with synthetic organic chemicals. Antiretroviral drugs, such as efavirenz and nevirapine, are pharmaceutical drugs and are referred to as emerging contaminants.
C. Schoeman, M. Dlamini, O.J. Okonkwo
doaj   +1 more source

Nevirapine Hepatotoxicity: Case Report and Discussion

, 2012
Nevirapine (viramune) is a nonnucleoside reverse transcriptase inhibitor commonly used in combination with other antiretroviral medicines in the treatment of HIV/AIDS.
Baichi, Matt
core   +1 more source

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

PLoS ONE, 2017
BackgroundThe antiretroviral drug nevirapine and the antimalarial artemisinin-based combination therapy artemether-lumefantrine are commonly co-administered to treat malaria in the context of HIV.
Liusheng Huang, Vincent Carey, Jane C Lindsey, Florence Marzan, David Gingrich, Bobbie Graham, Linda Barlow-Mosha, Phionah K Ssemambo, Portia Kamthunzi, Sharon Nachman, Sunil Parikh, Francesca T Aweeka, IMPAACT P1079 protocol team   +12 more
doaj   +1 more source

Nevirapine-induced side effects in pregnant women: experience of a brazilian university hospital

Brazilian Journal of Infectious Diseases
Nevirapine-based therapy is associated with increased frequency of adverse events among HIV-infected pregnant women. The aim of this article was to evaluate the incidence of adverse effects in HIV-infected women who started nevirapine during pregnancy. A
William Kondo, Elaine Aparecida Carraro, Elaine Prandel, Josiane Mourão Dias, Juliane Perini, Rodolfo Lara de Macedo, Taynah Cristina Cornelsen, Renato Sbalquiero, Maria das Graças Sasaki   +8 more
doaj   +1 more source

Docking-MM-GB/SA and ADME screening of HIV-1 NNRTI inhibitor: Nevirapine and its analogues

, 2008
Nevirapine and its synthetic analogues, a class of non-nucleoside inhibitors (NNRTIs) of HIV-1 reverse transcriptase (RT), have been the objective of numerous studies focused to prepare better and safer anti-HIV drugs.
Verma, D., Sengupta, D., Naik, P.K.
core